SCHEDULE 13D/A
Beneficial Ownership Report
Silence Therapeutics plc Filed Acc 0001104659-25-062458
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-11-12 SCHEDULE 13G/A · Raymond Debbane 4.6%
- 2026-11-05 SCHEDULE 13G · FMR LLC 7.1%
- 2026-10-13 SCHEDULE 13G/A · Tetragon Financial Group Limited 5.3%
- 2026-10-13 SCHEDULE 13G · Tetragon Financial Group Limited 5.2%
- 2026-08-13 SCHEDULE 13G/A · Raymond Debbane 7.0%
- 2026-08-13 SCHEDULE 13D/A · Richard Griffiths 7.97%
Loading xslSCHEDULE_13D_X01/primary_doc.xml…